A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
Clinical trial NCT05891496 · COMPLETED
Trial details
- NCT number
- NCT05891496
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2024-08-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.